Skip to main content

Robin Energy Ltd. Reports Net Income of $0.5 Million for the Three Months Ended June 30, 2025 and $0.4 Million for the Six Months Ended June 30, 2025

LIMASSOL, Cyprus, Oct. 01, 2025 (GLOBE NEWSWIRE) — Robin Energy Ltd. (NASDAQ: RBNE), (“Robin”, or the “Company”), an international ship-owning company providing energy transportation services globally, today announced its results for the three months and the six months ended June 30, 2025. Highlights of the Second Quarter Ended June 30, 2025:Total vessel revenues: $2.0 million, as compared to $1.5 million for the three months ended June 30, 2024, or a 33.3% increase; Net income: $0.5 million, as compared to $0.2 million for the three months ended June 30, 2024, or a 150.0% increase; Earnings per common share, basic: $0.15 per share, as compared to $0.08 per share for the three months ended June 30, 2024; EBITDA(1): $0.7 million, as compared to $0.4 million for the three months ended June 30, 2024; Cash of $39.4 million as of...

Continue reading

NOVAGOLD Files Third Quarter 2025 Report

Successfully completed the transformative $1 billion acquisition1 of Barrick Mining Corporation’s (“Barrick Mining”) 50 percent interest in Donlin Gold on June 3, 2025, where NOVAGOLD increased its stake in Donlin Gold LLC to 60 percent, acquiring an additional 10 percent interest for $200 million, while funds managed by Paulson Advisers LLC (“Paulson”) secured a 40 percent interest for $800 million. Announced the full exercise of the underwriters’ option in the public offering on June 5, 2025, raising an additional $25.6 million as part of the financing at $3.75 per share. Strengthened the treasury of $125 million in cash and term deposits at the end of the third quarter with proceeds from the underwritten public offering of $195.2 million and a concurrent private placement of $64.4 million that funded the $200 million payment to increase...

Continue reading

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Inspira delivered major milestones throughout and following the six months ended June 30, 2025, including the receipt of $49.5 million in binding purchase orders, clinical validation in leading hospitals, 97.35% accuracy for its HYLA blood sensor, and strategic patent protection, underscoring accelerating commercial momentum. RA’ANANA, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (“Inspira” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced its financial results for the six-month period ended June 30, 2025, and issued a business update. “The first half of 2025 represents a pivotal transformation for Inspira as we have successfully transitioned from being a development-stage company to commencing commercial execution....

Continue reading

Rezolve Ai Raises 2025 Guidance to $150M ARR and Initiates 2026 Guidance to $500M ARR Exit Rate as Strong Growth Shatters Analyst Forecasts

$6.3M H1 Revenue (+426% YoY) vs. $5.1M Consensus Gross Margin at 95.8% vs. 60–70% Consensus Adjusted EBITDA1 $(17.7)M vs. $(18.7)M Consensus 100+ Enterprise Customers2 Including Ferrero, H&M, and Urban Outfitters Brain Suite Now Agentic Commerce Ready brainpowa Whitepaper Confirms Competitive Performance vs GPT-4 and Claude, With Effectively Zero HallucinationsNEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in proprietary AI-powered commerce solutions and a partner of Microsoft, Google and Tether, today announced first half 2025 results that materially outperformed analyst expectations, underscoring the Company’s accelerating momentum with global enterprises and its expanding role as the AI engine of commerce.Revenue surged to $6.3 million in H1 2025, surpassing the $5.1 million analyst...

Continue reading

Acuity Reports Fiscal 2025 Fourth-Quarter and Full-Year Results

Strong Execution in the Fourth-Quarter Delivered Net Sales Growth and Improved Operating PerformanceIncreased Fiscal Q4 2025 Net Sales 17% to $1.2B Compared to the Prior Year Reported Fiscal Q4 2025 Diluted EPS of $3.61, down 4% Over the Prior Year; Adjusted Diluted EPS of $5.20, up 21% Over the Prior Year Delivered Fiscal 2025 Net Sales of $4.3B, a 13% Increase Compared to the Prior Year Reported Fiscal 2025 Diluted EPS of $12.53, down 7% Over the Prior Year; Adjusted Diluted EPS of $18.01, up 16% Over the Prior Year Generated $601M in Cash Flow from Operations in Fiscal 2025ATLANTA, Oct. 01, 2025 (GLOBE NEWSWIRE) — Acuity Inc. (NYSE: AYI) (the “Company”), a market-leading industrial technology company, delivered net sales of $1.2 billion in the fourth quarter of fiscal 2025 ended August 31, 2025, an increase...

Continue reading

Cal-Maine Foods Reports Strongest First Quarter in Company History

Specialty Eggs and Prepared Foods Positioned as Growth Engines, Anchored by Scale, Integration, and Financial Strength RIDGELAND, Miss., Oct. 01, 2025 (GLOBE NEWSWIRE) — Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today reported results for the first quarter of fiscal 2026, ended August 30, 2025. Unless otherwise indicated, all comparisons are to the comparable period of fiscal 2025. Financial and Operating HighlightsNet sales of $922.6 million, up 17.4%Shell egg sales of $789.4 million, up 6.5%Conventional egg sales of $505.9 million, up 4.4% Specialty egg sales of $283.5 million, up 10.4% Conventional eggs and specialty eggs accounted for 64.1% and 35.9% of total shell egg sales, compared to 65.4% and 34.6%, respectivelyPrepared...

Continue reading

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results

PARIS and CAMBRIDGE, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, provided an update on operational progress and announced its half year financial results for the six-month period ended June 30, 2025. Operational Highlights of the 2025 Half Year Period and To Date Expanding clinical development program evaluating the potential broad applicability of JNJ-1900 (NBTXR3) continues to build significant momentum:First patient dosed in the CONVERGE study, a Johnson & Johnson (“J&J”)-sponsored randomized Phase 2 study evaluating JNJ-1900 (NBTXR3) for patients with Stage 3 unresectable non-small...

Continue reading

Results of Operations for the Three Months Ended June 30, 2025 – American Overseas Group Limited Announces Net Income Of $2.5 Million For the Three Months Ended June 30, 2025

HAMILTON, Bermuda, Sept. 30, 2025 (GLOBE NEWSWIRE) — American Overseas Group Limited (BSX: AORE.BH) (Pink Sheets: AOREF.PK) (“AOG” or the “Company”) today reported consolidated net income available to common shareholders of $2.5 million, or $53.51 per diluted share, for the three months ended June 30, 2025. This compares to consolidated net income available to common shareholders of $2.3 million, or $49.81 per diluted share, for the three months ended June 30, 2024. Book value per weighted share at June 30, 2025 was $1,139.67, an increase from the book value per weighted share of $873.62 at June 30, 2024. For the three months ended June 30, 2025, net earned property and casualty premiums increased $0.1 million from $12.7 million a year ago to $12.8 million. Quarter to Date fee income increased $0.3 million from $5.1 million to...

Continue reading

Top Wealth Group Holding Limited Announces First Half 2025 Unaudited Financial Results

— First Half Revenue of $4.2 million, decrease 5.6% year-over-year —— First Half Net Profits of $2.4 million, versus Net Loss of $0.5 million last year — HONG KONG, Sept. 30, 2025 (GLOBE NEWSWIRE) — Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), a company that specializes in supplying premium-class sturgeon caviar, today announced its unaudited financial results for the six months ended June 30, 2025. First Half 2025 Financial Results Sales Sales for the first half 2025 were $4.2 million, representing a decrease of 5.6% from $4.4 million in the same period of 2024. During the period we have rebuilt our wine distribution business. Total cost and operating expenses were $1.8 million in the first half of 2025, a decrease of 64.7% from $5.0 million in the same period of 2024.Cost...

Continue reading

Societe Generale SFH : Availability of the 2025 Half-Year Financial Report

SOCIETE GENERALE SFH : AVAILABILITY OF THE HALF-YEAR FINANCIAL REPORT Regulated Information Paris, 30 September 2025 Societe Generale SFH (“Société de Financement de l’Habitat”, Home Loans SFH) hereby informs the public that the half-year financial report for the period ended 30 June 2025 has been filed with the French Financial Markets Authority (AMF) on 30 September 2025. This document, available in French only, is made available to the public, free of charge, in accordance with the conditions provided for by the regulations in force and may be consulted in the “Societe Generale Home Loans SFH / Regulated information » section of the Societe Generale group’s website (https://investors.societegenerale.com/en/financial-and-non-financial-information/debt-investors) and on the AMF’s website. Press contacts:Jean-Baptiste Froville_+33 1 58...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.